Choksi Laboratories

Choksi Laboratories EBIT

The EBIT of Choksi Laboratories (526546.BO) as of Oct 21, 2026 is 54.30 M INR. In the previous year, EBIT was 47.36 M INR — a change of 14.65% (higher).

EBIT

54.30 MINR

YoY

14.65%

Last updated:

In 2026, Choksi Laboratories's EBIT was 54.30 M INR, a 14.65% increase from the 47.36 M INR EBIT recorded in the previous year.

The Choksi Laboratories EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT
Date
EBIT
Jan 1, 2019
35.86 M INR
Jan 1, 2020
-34.50 M INR
Jan 1, 2021
-4.78 M INR
Jan 1, 2022
34.82 M INR
Jan 1, 2023
69.97 M INR
Jan 1, 2024
45.09 M INR
Jan 1, 2025
47.36 M INR
Jan 1, 2026
54.30 M INR
The Choksi Laboratories EBIT history
YEAREBITYoY
54.30 MINR+14.65%
47.36 MINR+5.02%
45.09 MINR-35.56%
69.97 MINR+100.96%
34.82 MINR-828.32%
-4.78 MINR-86.14%
-34.50 MINR-196.19%
35.86 MINR+13.09%
31.71 MINR+31.79%
24.06 MINR-2.56%
24.69 MINR+6.93%
23.09 MINR-16.35%
27.61 MINR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Choksi Laboratories Revenue

Choksi Laboratories Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2019
337.46 M INR
35.86 M INR
16.00 M INR
Jan 1, 2020
281.59 M INR
-34.50 M INR
-38.85 M INR
Jan 1, 2021
256.88 M INR
-4.78 M INR
-26.08 M INR
Jan 1, 2022
300.42 M INR
34.82 M INR
2.07 M INR
Jan 1, 2023
344.41 M INR
69.97 M INR
32.10 M INR
Jan 1, 2024
366.95 M INR
45.09 M INR
11.10 M INR
Jan 1, 2025
417.82 M INR
47.36 M INR
15.23 M INR
Jan 1, 2026
460.06 M INR
54.30 M INR
19.64 M INR

Choksi Laboratories Margins

Choksi Laboratories stock margins

The Choksi Laboratories margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Choksi Laboratories. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Choksi Laboratories.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2019
88.31 %
10.63 %
4.74 %
Jan 1, 2020
88.48 %
-12.25 %
-13.80 %
Jan 1, 2021
87.46 %
-1.86 %
-10.15 %
Jan 1, 2022
91.07 %
11.59 %
0.69 %
Jan 1, 2023
93.58 %
20.32 %
9.32 %
Jan 1, 2024
93.03 %
12.29 %
3.02 %
Jan 1, 2025
92.58 %
11.33 %
3.65 %
Jan 1, 2026
88.86 %
11.80 %
4.27 %

Choksi Laboratories Stock analysis

What does Choksi Laboratories do? Choksi Laboratories Ltd. generates revenue through contract laboratory services for pharmaceuticals, food, agricultural products, construction materials, and chemicals, as well as calibration and validation services for test equipment and process equipment. The company provides environment management services, clinical research, consultancy, and assaying and hallmarking to clients requiring regulatory compliance or analytical testing. Its clients include entities needing pharmaceutical analysis, food and beverage analysis, water analysis, and construction material analysis, alongside those seeking instrument calibration, plant shutdown calibration, and consultancy for in-house calibration laboratories. The firm serves segments such as pharmaceutical manufacturers, food producers, agricultural businesses, construction firms, and environmental management organizations through its comprehensive suite of analytical and calibration solutions. The company's revenue streams include contract laboratory services for pharmaceuticals, food, and agricultural products, alongside calibration services for laboratory and on-site equipment, process equipment, and end-user equipment. Clients utilize these services for regulatory compliance, quality assurance, and operational efficiency, with specific demand from pharmaceutical companies requiring drug testing, food manufacturers needing safety analysis, and construction firms requiring material testing. Choksi Laboratories Ltd. also offers consultancy services for setting up in-house calibration laboratories, catering to organizations aiming to streamline their internal quality control processes. Choksi Laboratories Ltd. delivers analytical testing for pharmaceuticals, food, agricultural products, construction materials, and chemicals, with clients including pharmaceutical manufacturers, food producers, and construction firms. Its calibration services target organizations needing instrument validation and process equipment maintenance, while environment management services support businesses focused on environmental compliance. The company’s consultancy services, including training and third-party inspection, further enhance its offerings for clients requiring specialized expertise in regulatory and quality assurance domains. Choksi Laboratories is one of the most popular companies on Eulerpool.

EBIT Details

Analyzing Choksi Laboratories's EBIT

Choksi Laboratories's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Choksi Laboratories's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Choksi Laboratories's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Choksi Laboratories’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Choksi Laboratories stock

EBIT of Choksi Laboratories is 54.30 M INR in 2026.

EBIT of Choksi Laboratories changed from 47.36 M INR to 54.30 M INR, representing a 14.65% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT Choksi Laboratories since 2006 – with annual values, charts, and detailed analysis.

"Earnings before interest and taxes", abbreviated as EBIT, is also referred to as the operating result of a company. It is a key figure that allows the profit to be assessed over a specific period of time, usually a fiscal year. Taxes and interest are not deducted from EBIT, making it suitable for international comparisons of different companies.

Net income
+ Tax expense
+ Interest expense and other financial expenses
- Interest income and other financial income
= EBIT (operating profit)

EBIT's INR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT's Choksi Laboratories historically and in real time.

The sales revenue is important for evaluating a stock.

EBIT is an acronym for "Earnings Before Interest and Tax" and represents a company's gross profit before taxes and interest are deducted. The EBIT amount is often used as a metric to evaluate a company.

History

The EBIT was originally introduced in the 1940s when the US Internal Revenue Service (IRS) passed a new tax law. This law required companies to calculate their profit before deducting taxes and interest on loans (or "interest and taxes"). Since then, the EBIT has been used as one of the key financial indicators in evaluating a company.

Usage

The EBIT can be used to assess a company by comparing its financial results to a benchmark or a comparative value. The EBIT is also used to determine how much the company's shareholders will receive from its operating income.

Calculation

EBIT is calculated by deducting taxes and interest on loans from the company's net profit. This amount can be calculated in various ways, but the most common method is as follows:

EBIT = Net profit + interest and taxes

Example: Eulerpool: Your source for quantitative stock data At Eulerpool, we are dedicated to providing you with comprehensive and accurate stock information. Our website offers a wide range of tools and features, including charts, stock lists, and more. Whether you are an experienced investor or just starting out, our platform is designed to meet your needs. With our in-depth analytics and algorithms, you can make informed decisions and stay ahead of the market. Explore our extensive collection of stocks, track their performance, and access real-time data. With Eulerpool, you can easily navigate the world of finance and monitor the stocks that matter to you. Join our community today and gain valuable insights into the world of stocks and investments. Sign up for free and discover the power of Eulerpool. Stay informed. Stay ahead. Eulerpool - your trusted partner in stock data.
Net profit of XYZ Co. = $1,000,000
Interest and taxes = $ 500,000
EBIT of XYZ Co. = $1,500,000

Application

The EBIT value is often used to determine and evaluate the financial stability of a company. The EBIT value can also be used to determine how much money a company can spend on investments or dividends.

Use of EBIT in stock investment

Investors use EBIT to determine if a stock is over- or undervalued. If a company has a high EBIT value, it may indicate that its stock is overvalued, as the profit it generates could be lower than what it would generate with a different stock.

Advantages of EBIT

EBIT is a helpful measure for determining the financial stability of a company. There are several advantages associated with using EBIT, such as:
- EBIT eliminates the impact of financing on the company's earnings.
- It is a useful measure for determining the profits that a company can distribute to its shareholders.
- It can be used to determine whether a stock is overvalued or undervalued.

Disadvantages of EBIT

There are also some disadvantages to using EBIT, such as:
- EBIT cannot be used as the sole measure to evaluate a company as it does not reflect the overall profit of the company.
- EBIT can be influenced by unforeseen events such as a tax increase.
- EBIT is not always a reliable indicator of a company's future profit development.

Conclusion

The EBIT is an important measure used to evaluate a company. It can be used to determine how much money a company can generate from its operational results and whether a stock is overvalued or undervalued. However, the EBIT also has some disadvantages as it does not reflect the overall profitability of a company and can be influenced by unforeseen events. Therefore, it is important to consider the EBIT in conjunction with other financial indicators to obtain a complete picture of the company.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Choksi Laboratories

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Choksi Laboratories